Analyst IMS Investment Management Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Analyst IMS Investment Management Services’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$889K	Hold	1,425	–	–	0.02%	105
2026 Q1	$1.1M	Hold	1,425	–	–	0.03%	83
2025 Q4	$1.1M	Hold	1,425	–	–	0.03%	76
2025 Q3	$801K	Hold	1,425	–	–	0.02%	92
2025 Q2	$748K	Hold	1,425	–	–	0.03%	99
2025 Q1	$904K	Hold	1,425	–	–	0.04%	92
2024 Q4	$1.01M	Hold	1,425	–	–	0.04%	82
2024 Q3	$1.5M	Hold	1,425	–	–	0.06%	67
2024 Q2	$1.5M	Hold	1,425	–	–	0.06%	59
2024 Q1	$1.37M	Hold	1,425	–	–	0.06%	56
2023 Q4	$1.25M	Hold	1,425	–	–	0.07%	54
2023 Q3	$1.19M	Hold	1,425	–	–	0.07%	48
2023 Q2	$1.01M	Hold	1,425	–	–	0.07%	53
2023 Q1	$1.16M	Sell	1,425 -62	-4%	-$46.8K	0.09%	48
2022 Q4	$1.07M	Sell	1,487 -290	-16%	-$214K	0.09%	53
2022 Q3	$1.23M	Sell	1,777 -73	-4%	-$45.9K	0.12%	47
2022 Q2	$1.09M	Sell	1,850 -370	-17%	-$241K	0.1%	58
2022 Q1	$1.55M	Sell	2,220 -630	-22%	-$399K	0.14%	49
2021 Q4	$1.83M	Buy	2,850 +40	+1%	+$24.6K	0.17%	53
2021 Q3	$1.7M	Sell	2,810 -75	-3%	-$46.6K	0.21%	51
2021 Q2	$1.61M	Buy	2,885 +80	+3%	+$40.5K	0.19%	53
2021 Q1	$1.33M	Buy	2,805 +740	+36%	+$360K	0.18%	54
2020 Q4	$998K	Buy	+2,065	New	+$1.11M	0.17%	59
2018 Q4	–	Sell	-140	Closed	-$57K	–	151
2018 Q3	$57K	Buy	+140	New	+$53.3K	0.01%	129

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Analyst IMS Investment Management Services's REGN Position: Q2 2026 in Review

Analyst IMS Investment Management Services held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 1,425 shares worth $889K. The position accounts for 0.02% of the portfolio, ranked #105.

Analyst IMS Investment Management Services first reported a position in REGN in Q3 2018 and has held it in 24 quarters since. The position peaked at $1.83M in Q4 2021. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Analyst IMS Investment Management Services held 1,425 shares of Regeneron Pharmaceuticals worth $889K as of Q2 2026.
Analyst IMS Investment Management Services left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.02% of Analyst IMS Investment Management Services's portfolio in Q2 2026, its #105 holding.
Analyst IMS Investment Management Services first reported a position in Regeneron Pharmaceuticals in Q3 2018 and has held it in 24 quarters since.
Analyst IMS Investment Management Services's Regeneron Pharmaceuticals position peaked at $1.83M in Q4 2021.
1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Analyst IMS Investment Management Services's 13F filing for Q2 2026, filed 29 Jul 2026.